Pays: Canada
Langue: français
Source: Health Canada
Firocoxib
BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
57MG
Comprimé (à mâcher)
Firocoxib 57MG
Orale
15G/50G
Prescription
Chiens
Numéro de groupe d'ingrédients actifs (GIA) :0152300001
APPROUVÉ
2020-06-10
BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. PREVICOX ® (FIROCOXIB) 57 MG & 227 MG TABLETS /PROPOSED LABELING COMPONENTS BI AH Canada Inc. Version dated 07Jun2023 PACKAGE INSERT - EN PR PREVICOX ® (FIROCOXIB) Chewable Tablets for Dogs VETERINARY USE ONLY DIN 02300168 (57mg)/DIN 02300176 (227mg) _DESCRIPTION_: Previcox ® (firocoxib) is a selective COX-2 enzyme inhibiting-class, non- narcotic, non-steroidal anti-inflammatory drug. Firocoxib is a white crystalline compound described chemically as 3-(cyclopropylmethoxy)-4-(4-(methylsulfonyl) phenyl)-5,5- dimethylfuranone. The empirical formula is C 17 H 20 0 5 S, and the molecular weight is 336.4 g/mol. The structural formula is: _INDICATIONS_: Previcox ® (firocoxib) chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. _DOSAGE AND ADMINISTRATION:_ For OSTEOARTHRITIS, the recommended dosage of Previcox ® (firocoxib) for oral administration in dogs is 5 mg/kg body weight once daily. For post- operative pain and inflammation following SOFT-TISSUE and ORTHOPEDIC SURGERY, the recommended dosage is 5 mg/kg body weight once daily, starting approximately 2 hours prior to surgery and for 2 additional days. Previcox ® tablets are scored and dosage should be calculated in half tablet increments. DUE TO TABLET SIZE AND SCORING, DOGS WEIGHING LESS THAN 5.7 KG (12.5 LBS) CANNOT BE ACCURATELY DOSED. Previcox ® tablets may be administered with or without food. OWNERS SHOULD BE INFORMED OF THE POTENTIAL ADVERSE REACTIONS AND CLINICAL SIGNS ASSOCIATED WITH NSAID INTOLERANCE. ALWAYS PROVIDE CLIENT INFORMATION SHEET WITH PRESCRIPTION. DOGS UNDERGOING PROLONGED TREATMENT WITH PREVICOX ® SHOULD BE MONITORED PERIODICALLY. _CONTRA-INDICATIONS:_ Do not administer Previcox ® or any NSAID if gastro-intestinal ulceration or bleeding is suspected. Do not administer concurrently with corticosteroids or other non- steroi Lire le document complet